Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma

Quality of pathological reporting for renal cell cancer: implications for systemic therapy, prognostication and surveillance

(2010) Brian Shuch et al.   BJU INTERNATIONAL

Histologic evaluation of metastases in renal cell carcinoma with sarcomatoid transformation and its implications for systemic therapy

(2009) Brian Shuch et al.   CANCER

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

(2009) Daniel Y.C. Heng et al.   JOURNAL OF CLINICAL ONCOLOGY

Cytoreductive Nephrectomy for Kidney Cancer With Sarcomatoid Histology—Is Up-Front Resection Indicated and, if Not, is it Avoidable?

(2009) Brian Shuch et al.   JOURNAL OF UROLOGY

Metastatic Sarcomatoid Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Therapy

(2008) Ali Reza Golshayan et al.   JOURNAL OF CLINICAL ONCOLOGY

Surgical Morbidity Associated With Administration of Targeted Molecular Therapies Before Cytoreductive Nephrectomy or Resection of Locally Recurrent Renal Cell Carcinoma

(2008) Vitaly Margulis et al.   JOURNAL OF UROLOGY